We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+11.34%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
+$83.5M
(+38%)
Cap. Flow
+$69.1M
Cap. Flow
% of AUM
22.88%
Top 10 Holdings %
Top 10 Hldgs %
15.66%
Holding
829
New
363
Increased
97
Reduced
44
Closed
323
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$10.7M |
| 2 |
Accenture
ACN
|
+$6.03M |
| 3 |
Adobe
ADBE
|
+$5.83M |
| 4 |
Lockheed Martin
LMT
|
+$2.67M |
| 5 |
Progressive
PGR
|
+$2.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.64M |
| 2 |
Newmont
NEM
|
+$2.55M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$2.33M |
| 4 |
Oracle
ORCL
|
+$2.24M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Financials | 14.46% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Healthcare | 12.24% |
| 5 | Industrials | 11.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Enviri
NVRI
$620M
| $148K | 0.05% |
17,082
-20,048
| -54% | -$147K |
|
452
Atea Pharmaceuticals
AVIR
$420M
| $147K | 0.05% |
40,787
+18,585
| +84% | +$55.4K |
|
453
DocGo
DCGO
$62.6M
| $146K | 0.05% |
93,126
+51,298
| +123% | +$95.6K |
|
|
AVNS
454
DELISTED
Avanos Medical
AVNS
| $146K | 0.05% |
11,922
+684
| +6% | +$8.6K |
|
455
Mativ Holdings
MATV
$711M
| $145K | 0.05% |
+21,210
| New | +$122K |
|
|
SNBR
456
DELISTED
Sleep Number
SNBR
| $144K | 0.05% |
+21,372
| New | +$163K |
|
|
ANTA
457
Antalpha Platform Holding Co
ANTA
$88.6M
| $143K | 0.05% |
+12,376
| New | +$151K |
|
458
Amplify Energy
AMPY
$166M
| $140K | 0.05% |
43,820
-15,014
| -26% | -$44.6K |
|
459
Rocket Pharmaceuticals
RCKT
$394M
| $134K | 0.04% |
54,801
+42,492
| +345% | +$215K |
|
460
Gray Television
GTN
$552M
| $134K | 0.04% |
29,471
+17,566
| +148% | +$68.1K |
|
461
Wendy's
WEN
$1.46B
| $131K | 0.04% |
+11,462
| New | +$140K |
|
462
Heartland Express
HTLD
$956M
| $130K | 0.04% |
+15,050
| New | +$129K |
|
463
Evolution Petroleum
EPM
$131M
| $127K | 0.04% |
+27,050
| New | +$123K |
|
464
Peloton Interactive
PTON
$2.49B
| $127K | 0.04% |
18,265
-15,142
| -45% | -$98.4K |
|
|
MTA
465
Metalla Royalty & Streaming
MTA
$818M
| $126K | 0.04% |
+32,934
| New | +$105K |
|
466
Replimune Group
REPL
$1.01B
| $125K | 0.04% |
+13,406
| New | +$117K |
|
467
Chemours
CC
$2.37B
| $124K | 0.04% |
+10,845
| New | +$122K |
|
468
Tactile Systems Technology
TCMD
$665M
| $124K | 0.04% |
+12,203
| New | +$139K |
|
|
GLDD
469
DELISTED
Great Lakes Dredge & Dock
GLDD
| $123K | 0.04% |
10,111
-9,914
| -50% | -$103K |
|
470
Arvinas
ARVN
$572M
| $123K | 0.04% |
16,705
+2,242
| +16% | +$16.5K |
|
471
LSB Industries
LXU
$693M
| $123K | 0.04% |
+15,760
| New | +$108K |
|
|
NSLR
472
Neostellar Capital Corp
NSLR
$254M
| $122K | 0.04% |
+14,866
| New | +$88.5K |
|
473
Vaalco Energy
EGY
$594M
| $118K | 0.04% |
+32,822
| New | +$114K |
|
474
Cogent Biosciences
COGT
$7.24B
| $114K | 0.04% |
+15,931
| New | +$88.3K |
|
|
STKL
475
DELISTED
SunOpta
STKL
| $109K | 0.04% |
+18,869
| New | +$99.1K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Oxford Asset Management held 829 positions worth $302M, up 38% from $219M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Oxford Asset Management deployed $69.1M of net new capital in Q2 2025, opening 363 new positions and adding to 97 existing holdings. Its largest new stake was Accenture: 19,786 shares worth $5.91M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Marvell Technology, an estimated $1.18M trimmed.
- Oxford Asset Management's largest Q2 2025 buy was Accenture: 19,786 shares worth $5.91M.
- Oxford Asset Management added most to State Street SPDR S&P Biotech ETF in Q2 2025, an estimated $10.7M increase.
- Oxford Asset Management's biggest Q2 2025 reduction was Marvell Technology, cutting an estimated $1.18M.
- Oxford Asset Management fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $2.64M.
- Oxford Asset Management's ten largest holdings make up 16% of its $302M portfolio in Q2 2025.
- Oxford Asset Management opened 363 new positions and closed 323 in Q2 2025.
- Oxford Asset Management's portfolio value rose 38% quarter-over-quarter to $302M.
Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.